(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DRUG SAFETY INSTITUTE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DRUG SAFETY INSTITUTE

ST13

US500000078390427

Class

35

Filing

78390427

Registration

2980285

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

02/04/2025

Trademark type

Word

Nice classes

35

Filing date

03/25/2004

Registration date

07/26/2005

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/10/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

04/30/2004

First use in commerce

04/30/2004

Drawing code

4

Owner type

03

Owner location

MIAMI, FL

Examiner

FRENCH, CURTIS

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BRAND INSTITUTE, INC.
Drug Safety Institute, Inc.

Representatives

Celina Collado BRAND INSTITUTE, INC.

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting servicesnamely providing risk assessment and analysis of proposed proprietary pharmaceutical product nameslabelingpackaging

Publications

History of USPTO decisions and trademark events.

36 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/10/2025

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

01/10/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/10/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/10/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

09/23/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/26/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/25/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/30/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/30/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/30/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/29/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

10/14/2014

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

12/14/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/13/2010

ES8R

TEAS SECTION 8 RECEIVED

11/15/2010

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

07/26/2005

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/31/2005

ALIE

ASSIGNED TO LIE

05/27/2005

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

05/26/2005

GNEA

EXAMINERS AMENDMENT E-MAILED

05/26/2005

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/26/2005

IUAA

USE AMENDMENT ACCEPTED

05/24/2005

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/23/2005

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

05/23/2005

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/03/2005

IUAF

USE AMENDMENT FILED

05/03/2005

EAAU

TEAS AMENDMENT OF USE RECEIVED

05/03/2005

GNRT

NON-FINAL ACTION E-MAILED

01/09/2005

CNRT

NON-FINAL ACTION WRITTEN

01/09/2005

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/24/2004

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/26/2004

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/26/2004

GNRT

NON-FINAL ACTION E-MAILED

10/12/2004

CNRT

NON-FINAL ACTION WRITTEN

10/12/2004

DOCK

ASSIGNED TO EXAMINER

10/11/2004

NWAP

NEW APPLICATION ENTERED

04/06/2004

Continuous trademark protection

Get notified about every new filing that threatens DRUG SAFETY INSTITUTE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.